Risk of malignancy in resected pancreatic mucinous cystic neoplasms

Keane, M.; Shamali, A.; Nilsson, L.; Antila, A.; Bocos, J.; Van Zanten, M.; Gil, C.; Maisonneuve, P.; Vaalavuo, Y.; Hoskins, T.; Robinson, S.; Ceyhan, GÜRALP; Abu Hilal, M.; Pereira, S.; Laukkarinen, J.; Del Chiaro, M.

doi:10.1002/bjs.10787

Risk of malignancy in resected pancreatic mucinous cystic neoplasms

Atıf İçin Kopyala

Keane M. G., Shamali A., Nilsson L. N., Antila A., Bocos J. M., Van Zanten M. M., ...Daha Fazla

BRITISH JOURNAL OF SURGERY, cilt.105, sa.4, ss.439-446, 2018 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 105 Sayı: 4
Basım Tarihi: 2018
Doi Numarası: 10.1002/bjs.10787
Dergi Adı: BRITISH JOURNAL OF SURGERY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.439-446
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Pancreatic mucinous cystic neoplasms (MCNs) are rare mucin-producing cystic tumours defined by the presence of ovarian-type stroma. MCNs have a malignant potential and thus surgery is frequently performed. The aim of this cohort study was to define better the criteria for surgical resection in patients with MCN.